Zero sum game? Bristol-Myers shuffles research jobs
This article was originally published in Scrip
Executive Summary
Bristol-Myers Squibb will relocate research and development employees to new sites on the East Coast and expand its West Coast presence, but the big biopharma company does not anticipate major job losses due to its R&D reshuffling strategy even after eliminating virology drug discovery efforts.